We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$568M
AUM Growth
+$55.3M
Cap. Flow
+$7.09M
Cap. Flow %
1.25%
Top 10 Hldgs %
82.48%
Holding
77
New
5
Increased
9
Reduced
4
Closed
4

Top Buys

1
KZIA
Kazia Therapeutics
KZIA
+$3.41M
2
DTIL icon
Precision BioSciences
DTIL
+$3.33M
3
PXLW icon
Pixelworks
PXLW
+$1.54M
4
GPGI
GPGI Inc
GPGI
+$1.1M
5
EYPT icon
EyePoint Inc
EYPT
+$850K

Top Sells

1
LIN icon
Linde
LIN
+$3M
2
CMPOW
CompoSecure Inc Warrant
CMPOW
+$1.28M
3
FEAM icon
5E Advanced Materials
FEAM
+$997K
4
EVOK
Evoke Pharma
EVOK
+$728K
5
GPCR icon
Structure Therapeutics
GPCR
+$408K

Sector Composition

1 Industrials 28.25%
2 Healthcare 13.73%
3 Technology 6.13%
4 Materials 5.73%
5 Financials 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVOK
76
DELISTED
Evoke Pharma
EVOK
– –
-146,395
Closed -$728K
FEAM icon
77
5E Advanced Materials
FEAM
$47.7M
– –
-285,714
Closed -$997K
1 2 3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q4 2025 Portfolio in Review

As of Q4 2025, Bleichroeder LP held 77 positions worth $568M, up 11% from $513M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2025 filing shows 5 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Kazia Therapeutics: 400,000 shares worth $2.76M. The largest sale was Linde, an estimated $3M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

  • Bleichroeder LP's largest Q4 2025 buy was Kazia Therapeutics: 400,000 shares worth $2.76M.
  • Bleichroeder LP added most to Precision BioSciences in Q4 2025, an estimated $3.33M increase.
  • Bleichroeder LP's biggest Q4 2025 reduction was Linde, cutting an estimated $3M.
  • Bleichroeder LP fully exited CompoSecure Inc Warrant in Q4 2025, selling an estimated $1.28M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $568M portfolio in Q4 2025.
  • Bleichroeder LP opened 5 new positions and closed 4 in Q4 2025.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $568M.

Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.